{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:02:15Z","timestamp":1767045735760,"version":"3.48.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Otorrinolaringologica (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.otoeng.2025.512291","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T23:18:49Z","timestamp":1759706329000},"page":"512291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-life outcomes of benralizumab treatment in chronic rhinosinusitis with nasal polyps: The BenREALizumab study"],"prefix":"10.1016","volume":"76","author":[{"given":"Juan","family":"Maza-Solano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Merino-Boh\u00f3rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"G\u00f3mez-Bastero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Delgado-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seraf\u00edn","family":"S\u00e1nchez-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl S29","key":"10.1016\/j.otoeng.2025.512291_bib0005","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.otoeng.2025.512291_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11882-023-01074-1","article-title":"The comorbid patient in the spotlight: efficacy of Benralizumab on chronic rhinosinusitis with nasal polyp outcomes in presence of severe asthma","volume":"23","author":"De Corso","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.otoeng.2025.512291_bib0015","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/cea.13852","article-title":"Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): a randomized double-blind placebo-controlled trial","volume":"51","author":"Tversky","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.otoeng.2025.512291_bib0020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.otoeng.2025.512291_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106080","article-title":"Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis","volume":"171","author":"Bagnasco","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.otoeng.2025.512291_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420950851","article-title":"Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma","volume":"34","author":"Lombardo","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"12","key":"10.1016\/j.otoeng.2025.512291_bib0035","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1016\/j.jaip.2021.08.004","article-title":"Benralizumab effectiveness in severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: a real-world multicenter study","volume":"9","author":"Nolasco","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.otoeng.2025.512291_bib0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/1945892420978351","article-title":"Effect of Benralizumab in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a case series","volume":"35","author":"Chitguppi","year":"2021","journal-title":"Am J Rhinol Allergy"},{"issue":"10","key":"10.1016\/j.otoeng.2025.512291_bib0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/resp.14767","article-title":"Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis","volume":"29","author":"Pelaia","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.otoeng.2025.512291_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2022.06.009","article-title":"Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a pilot real-life study","volume":"248","author":"Cavaliere","year":"2022","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.otoeng.2025.512291_bib0055","article-title":"Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study","volume":"94","author":"Santomasi","year":"2023","journal-title":"Acta Biomed"},{"issue":"2","key":"10.1016\/j.otoeng.2025.512291_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-022-08938-w","article-title":"Real-life effectiveness of Benralizumab, Mepolizumab and Omalizumab in severe allergic asthma associated with nasal polyps","volume":"64","author":"Tiotiu","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.otoeng.2025.512291_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0054.9674","article-title":"Results of personalized biological therapy in patients with chronic rhinosinusitis with nasal polyps and severe uncontrolled bronchial asthma - real-life study","volume":"79","author":"Jura-Szoltys","year":"2025","journal-title":"Otolaryngol Pol"},{"issue":"5","key":"10.1016\/j.otoeng.2025.512291_bib0070","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/all.16499","article-title":"Efficacy and safety of biologics for chronic rhinosinusitis with nasal polyps: a meta-analysis of real-world evidence","volume":"80","author":"Cai","year":"2025","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.otoeng.2025.512291_bib0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/87551225221105749","article-title":"Efficacy and safety of biologics for chronic rhinosinusitis with nasal polyps","volume":"38","author":"Koski","year":"2022","journal-title":"J Pharm Technol"}],"container-title":["Acta Otorrinolaringologica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573525000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573525000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:57:38Z","timestamp":1767045458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173573525000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2173573525000894"],"URL":"https:\/\/doi.org\/10.1016\/j.otoeng.2025.512291","relation":{},"ISSN":["2173-5735"],"issn-type":[{"type":"print","value":"2173-5735"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life outcomes of benralizumab treatment in chronic rhinosinusitis with nasal polyps: The BenREALizumab study","name":"articletitle","label":"Article Title"},{"value":"Acta Otorrinolaringologica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otoeng.2025.512291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Otorrinolaringolog\u00eda y Cirug\u00eda de Cabeza y Cuello. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"512291"}}